Melius Research Initiates Coverage On Toll Brothers with Buy Rating, Announces Price Target of $179
Melius Research initiates coverage on Toll Brothers (NYSE:TOL) with a Buy rating and announces Price Target of $179.
Stocks · News reference
Barclays analyst Matthew Bouley maintains Toll Brothers (NYSE:TOL) with a Underweight and lowers the price target from $122 to $118.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Melius Research initiates coverage on Toll Brothers (NYSE:TOL) with a Buy rating and announces Price Target of $179.
Analysts initiated bullish coverage on Vita Coco, Toll Brothers, Civeo, Teva and Kura Oncology, with price targets of $70, $159, $42, $55 and $30.